Sign in
8-K

Current Report

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-028734

Material agreement · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing